So it happened again. An underreported story about a half-baked advance in cancer medicine caught fire and scorched its way through social media, onto network TV, and into the minds of millions of people.
To start, no. There won’t be “a complete cure for cancer” in a year’s time, as the chairman of a small Israeli biotechnology firm predicted to the Jerusalem Post. The claim, absurd on its face, was particularly frustrating to those who work in medicine and drug development because it seemed so obvious there was not enough evidence to make it.